Mesenchymal Cell News Volume 15.00 | Jan 3 2023

    0
    15








    2023-01-03 | MESCN 15.00


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 15.00 – 3 January, 2023
    TOP STORY

    Hydrogel Viscoelasticity Modulates Migration and Fusion of Mesenchymal Stem Cell Spheroids

    The authors investigated the effect of viscoelasticity on the migration and fusion behavior of MSC spheroids using hydrogels with similar elasticity but different stress relaxation profiles.
    [Bioengineering & Translational Medicine]

    Full Article
    Listen to the Stem Cell Podcast episodes covering ISSCR 2022 sessions.
    PUBLICATIONSRanked by the impact factor of the journal

    AMPK Regulates DNA Methylation of PGC-1α and Myogenic Differentiation in Human Mesenchymal Stem Cells

    Scientists investigated the effects of pharmaceutical activation of AMPK, an essential regulator of energy metabolism, on mitochondrial programming of Wharton’s Jelly MSCs from women with diabetes during pregnancy.
    [Stem Cells and Development]

    Abstract

    TAZ Promotes Osteogenic Differentiation of Mesenchymal Stem Cells Line C3H10T1/2, Murine Multi-Lineage Cells Lines C2C12, and MEFs Induced by BMP9

    The authors investigated the effects of TAZ in BMP9-induced osteogenic differentiation of MSCs and murine multi-lineage cell lines C2C12 and MEFs and explored its possible mechanisms.
    [Cell Death Discovery]

    Full Article

    MEG3 Alleviates Ankylosing Spondylitis by Suppressing Osteogenic Differentiation of Mesenchymal Stem Cells through Regulating microRNA-125a-5p-Mediated TNFAIP3

    Overexpression of MEG3 and TNFAIP3 or inhibition of miR-125a-5p was found to inactivate the Wnt/β-catenin pathway, thus suppressing osteogenic differentiation of MSCs.
    [Apoptosis]

    Abstract

    Dynamic Expression of Mage-D1 in Rat Dental Germs and Potential Role in Mineralization of Ectomesenchymal Stem Cells

    Scientists investigated the expression pattern of Mage-D1 in rat dental germ development and its differential mineralization ability to ectomesenchymal stem cells.
    [Scientific Reports]

    Full Article

    C5L2 Modulates BDNF Production in Human Dental Pulp Stem Cells via p38α Pathway

    Investigators demonstrated that C5L2 modulated brain-derived neurotrophic factor secretion in human dental pulp stem cells.
    [Scientific Reports]

    Full Article

    ZDHHC16 Restrains Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells by Inhibiting Phosphorylation of CREB

    Researchers revealed that palmitic acid inhibited Runx2 mRNA expression in human bone marrow MSCs and identified ZDHHC16 as a potential target palmitoyl acyltransferase.
    [Heliyon]

    Full Article

    Human Dental Pulp Stem Cell Monolayer and Spheroid Therapy after Spinal Motor Root Avulsion in Adult Rats

    The application of human dental pulp stem cells in 2D and 3D was performed by microsurgery, with subsequent functional assessment on rat models with spinal motor root avulsion.
    [Brain Research]

    AbstractGraphical Abstract

    Autogenous Dentin Combined with Mesenchymal Stromal Cells as an Alternative Alveolar Bone Graft: An In Vivo Study

    Researchers evaluated the effect of dentin matrix alone or combined with MSCs on postextraction alveolar bone regeneration.
    [Clinical Oral Investigations]

    Abstract

    Extracellular Vesicles from Mesenchymal Stem Cells Reduce Neuroinflammation in Hippocampus and Restore Cognitive Function in Hyperammonemic Rats

    Scientists assessed whether the treatment of hyperammonemic rats with extracellular vesicles from MSCs restores cognitive function and analyzed the underlying mechanisms.
    [Journal of Neuroinflammation]

    Full Article
    STEMCELL has implemented an Environmental Management System that is now ISO 14001-certified.
    REVIEWS

    Therapeutic Potential of Mesenchymal Stromal/Stem Cells in Critical-Care Patients with Systemic Inflammatory Response Syndrome

    Investigators explore the potential of MSCs to aid in the recovery of patients with systemic inflammatory response syndrome and the pre-clinical and early clinical evidence generated to date.
    [Clinical And Translational Medicine]

    Full Article

    Recent Advances in Mesenchymal Stem Cells Therapy for Atopic Dermatitis

    Scientists review the recent understanding of atopic dermatitis (AD) pathology and advances in preclinical and clinical studies of MSCs, MSCs-derived conditional media, and exosomes as therapeutic tools to treat AD.
    [Journal Of Cellular Biochemistry]

    Full Article
    INDUSTRY AND POLICY NEWS

    Kala Pharmaceuticals Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCED

    Kala Pharmaceuticals, Inc. announced that the US FDA has accepted an investigational new drug (IND) application for KPI-012, a human MSC secretome, initially in development for the treatment of persistent corneal epithelial defect (PCED).
    [Kala Pharmaceuticals, Inc.]

    Press Release
    FEATURED EVENT

    Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy

    January 29 – February 2, 2023
    Banff, Alberta, Canada

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Computational Biology

    German Cancer Research Center in the Helmholtz Association – Heidelberg, Germany

    Postdoctoral Position – Tissue Regeneration Engineering

    Dankook University – Seoul, South Korea

    PhD Position – Precision Sarcoma Research

    German Cancer Research Center in the Helmholtz Association – Heidelberg, Germany

    Postdoctoral Fellow – Osteoarthritis

    Oklahoma Medical Research Foundation – Oklahoma City, Oklahoma, United States

    Postdoctoral Scientist – Cancer Therapeutics

    UTHSC-Houston – Houston, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter